Cargando…
Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789837/ https://www.ncbi.nlm.nih.gov/pubmed/31546795 http://dx.doi.org/10.3390/ncrna5030047 |
_version_ | 1783458704794845184 |
---|---|
author | Cascione, Luciano Giudice, Luca Ferraresso, Serena Marconato, Laura Giannuzzi, Diana Napoli, Sara Bertoni, Francesco Giugno, Rosalba Aresu, Luca |
author_facet | Cascione, Luciano Giudice, Luca Ferraresso, Serena Marconato, Laura Giannuzzi, Diana Napoli, Sara Bertoni, Francesco Giugno, Rosalba Aresu, Luca |
author_sort | Cascione, Luciano |
collection | PubMed |
description | Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine species as spontaneous animal tumor models are undeniably needed. Recent work using human DLBCL transcriptomes has suggested that long non-coding RNAs (lncRNAs) play a key role in lymphoma pathogenesis and pinpointed a restricted number of lncRNAs as potential targets for further studies. Results: To expand the knowledge of non-coding molecules involved in canine BCL, we used transcriptomes obtained from a cohort of 62 dogs with newly-diagnosed multicentric DLBCL, MZL and FL that had undergone complete staging work-up and were treated with chemotherapy or chemo-immunotherapy. We developed a customized R pipeline performing a transcriptome assembly by multiple algorithms to uncover novel lncRNAs, and delineate genome-wide expression of unannotated and annotated lncRNAs. Our pipeline also included a new package for high performance system biology analysis, which detects high-scoring network biological neighborhoods to identify functional modules. Moreover, our customized pipeline quantified the expression of novel and annotated lncRNAs, allowing us to subtype DLBCLs into two main groups. The DLBCL subtypes showed statistically different survivals, indicating the potential use of lncRNAs as prognostic biomarkers in future studies. Conclusions: In this manuscript, we describe the methodology used to identify lncRNAs that differentiate B-cell lymphoma subtypes and we interpreted the biological and clinical values of the results. We inferred the potential functions of lncRNAs to obtain a comprehensive and integrative insight that highlights their impact in this neoplasm. |
format | Online Article Text |
id | pubmed-6789837 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67898372019-10-16 Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization Cascione, Luciano Giudice, Luca Ferraresso, Serena Marconato, Laura Giannuzzi, Diana Napoli, Sara Bertoni, Francesco Giugno, Rosalba Aresu, Luca Noncoding RNA Article Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine species as spontaneous animal tumor models are undeniably needed. Recent work using human DLBCL transcriptomes has suggested that long non-coding RNAs (lncRNAs) play a key role in lymphoma pathogenesis and pinpointed a restricted number of lncRNAs as potential targets for further studies. Results: To expand the knowledge of non-coding molecules involved in canine BCL, we used transcriptomes obtained from a cohort of 62 dogs with newly-diagnosed multicentric DLBCL, MZL and FL that had undergone complete staging work-up and were treated with chemotherapy or chemo-immunotherapy. We developed a customized R pipeline performing a transcriptome assembly by multiple algorithms to uncover novel lncRNAs, and delineate genome-wide expression of unannotated and annotated lncRNAs. Our pipeline also included a new package for high performance system biology analysis, which detects high-scoring network biological neighborhoods to identify functional modules. Moreover, our customized pipeline quantified the expression of novel and annotated lncRNAs, allowing us to subtype DLBCLs into two main groups. The DLBCL subtypes showed statistically different survivals, indicating the potential use of lncRNAs as prognostic biomarkers in future studies. Conclusions: In this manuscript, we describe the methodology used to identify lncRNAs that differentiate B-cell lymphoma subtypes and we interpreted the biological and clinical values of the results. We inferred the potential functions of lncRNAs to obtain a comprehensive and integrative insight that highlights their impact in this neoplasm. MDPI 2019-09-19 /pmc/articles/PMC6789837/ /pubmed/31546795 http://dx.doi.org/10.3390/ncrna5030047 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cascione, Luciano Giudice, Luca Ferraresso, Serena Marconato, Laura Giannuzzi, Diana Napoli, Sara Bertoni, Francesco Giugno, Rosalba Aresu, Luca Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title | Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title_full | Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title_fullStr | Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title_full_unstemmed | Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title_short | Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization |
title_sort | long non-coding rnas as molecular signatures for canine b-cell lymphoma characterization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789837/ https://www.ncbi.nlm.nih.gov/pubmed/31546795 http://dx.doi.org/10.3390/ncrna5030047 |
work_keys_str_mv | AT cascioneluciano longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT giudiceluca longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT ferraressoserena longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT marconatolaura longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT giannuzzidiana longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT napolisara longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT bertonifrancesco longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT giugnorosalba longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization AT aresuluca longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization |